For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.

| Title | Content Type | Date | Description |
|---|---|---|---|
| Quetiapine (Seroquel and Seroquel XR) bipolar disorder listings expanded | Professional publication - NPS RADAR - Brief item | 2010-12-01 00:00:00 | From 1 December 2010, the streamlined authority listings of quetiapine (Seroquel) and quetiapine extended-release tablets (Seroquel XR) will include monotherapy for maintenance treatment of bipolar I disorder. |
| Quetiapine extended-release tablets (Seroquel XR) PBS listed for schizophrenia | Professional publication - NPS RADAR - Brief item | 2008-12-01 00:00:00 | Quetiapine extended-release tablets (Seroquel XR) were added to the Schedule of Pharmaceutical Benefits on 1 November 2008 as a streamlined authority-required listing for schizophrenia. The extended-release tablets come in different strengths to the existing immediate-release tablets, and dosing and administration has changed slightly. Prescribers will need to instruct patients carefully to prevent confusion between the two formulations. |
| Quetiapine (Seroquel) PBS listed for acute mania | Professional publication - NPS RADAR - Brief item | 2007-12-01 00:00:00 | PBS listing of quetiapine (Seroquel) was extended to include acute mania associated with bipolar disorder, with streamlined authority allowing an episode of acute mania to be treated for up to 6 months. |

NPS RADAR: independent, evidence-based assessment of new drugs, new PBS listings and the latest research for doctors, pharmacists and other health professionals.
Date published: 2009-10-30 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.